What's breaking now, across thousands of outlets.
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics.
More and more of our loved ones could develop dementia , as the number of diagnoses is projected to more than double by 2050, according to new research.
(MedPage Today) -- Patients with non-erosive reflux disease (NERD) who took once-daily tegoprazan -- a novel, fast-acting, oral potassium-competitive acid blocker (P-CAB) -- had a significant…
The first disease-modifying drugs for Alzheimer's disease offer patients the ability to slow cognitive decline by targeting amyloid plaques in the brain.
Does a nurse want a different kind of partner than an engineer? In a study of nearly 2,000 adults across seven countries, the industry people worked in had almost no link to what they prioritized in a…
Lab research suggests the little-studied peptide can form amyloid clumps and may damage neurons, but its role in Alzheimer’s patients remains unproven.
